Ready for Transfer

Microfluidics Device and Component Development

Dept. of Energy

Sandia National Laboratories has been working on the forefront of microfluidics device and component development for over twenty years and has amassed a sizable patent portfolio, a portion of which is now available for licensing as a bundle of 50+ patents for one simple fee. To further Sandia’s goal of disseminating and transferring taxpayer-funded technology into the private sector, this bundle is offered for non-exclusive licensing with an up-front fee of $25,000 and nominal periodic maintenance fees.

The inventions, devices, and methods comprising this intellectual property bundle were primarily developed in support of Sandia’s national security mission in chemical and biological defense, and as such, reflect an emphasis on compact, portable form factors and the low power and high reliability needed for extended field deployment. These bundled patents largely fall under three broad categories: chip-based devices and diagnostics, microfluidic interconnects and interfaces, and materials and fabrication methods. Licensed together, the contents of the bundle represent a broad-based suite of building blocks offering particular benefit to applications including laboratory automation, chemical and biological sample preparation and purification, separation science, analytical chemistry instrumentation, material synthesis, system integration, and biomedical diagnostics. Bundled patents include a number of capillary microfluidic valves and fittings, a unique digital microfluidic interface, methods for producing axisymmetric coaxial flow fields in a chip-based format. Also featured are interconnect devices which offer several components that can act as manifolds, check valves, or ultra-high pressure pumps. These can be used to construct devices that change the flow rate of the material and sample to detection units–including laser induced fluorescence, mass spectroscopy detectors, and flow cytometry. The fabrication materials and technologies allow the connections between microfluidic devices and external components while increasing the number of functional components that can be connected to a microfluidic device. Sandia National Laboratories does not sell its products and relies on licenses like this to commercialize its technology into unique devices that reflect an emphasis on portability and reliability.


  • Sample concentration & efficient delivery to chip
  • Mass manufacturing methods
  • Multiple fluidic connections
  • Increased number of external components


  • Bioscience R&D
  • Medical Point-of-Care
  • Remote Sampling
  • Pharmaceuticals
  • Veterinary

For more information about licensing opportunities, please contact Jackie Kerby-Moore at 505-845-8107 or